Pablo Amaya
@pablofneuro
Vascular neurologist Fundación Valle del Lili, neurology professor Icesi university, theater, #WSOFLP 1st cohort opinions of my own.
ID: 2208300873
05-12-2013 04:14:55
1,1K Tweet
1,1K Followers
1,1K Following
Thrilled to share that the OCEANIC-STROKE trial (NCT05686070), led by PHRI.ca Population Health Research Institute 🇨🇦 & Bayer | Pharmaceuticals, has successfully completed enrolment of over 12,300 participants with non-cardioembolic ischemic #stroke over a recruitment period of only 26-months! 🔗phri.ca/oceanicstroke/
Mechanical Thrombectomy for Large Ischemic Stroke: A Critical Appraisal of Evidence From 6 Randomized Controlled Trials ahajournals.org/doi/10.1161/ST… Stroke AHA/ASA
#MondayTip The stroke pathway and #ESOC2025 result Last week, Helsinki brought together the world’s leading stroke experts—leaving us with new evidence, fresh questions, and future challenges. All with one goal: improving outcomes for our patients European Stroke Org
Investigación para toma de decisiones basada en evidencia en políticas públicas Pablo M Lavados 3er congreso ACEVE Chile 🇨🇱 SIECV-IASO Camila Pantoja
1er Simposio de Neurología Vascular Ecuatoriano 🇪🇨 Genial oportunidad para aprender y compartir con amigos de LatAm Programa genial y profesores top José Biller Antonio Arauz Jorge G. Ortiz-Garcia, MD, MSCR, FAAN Alianza Joven Latinoamericana contra el ACV SIECV-IASO
#WSC2025 Late breaking trials #TRIDENT Intensive BP control w/ a single ‘triple pill’: telmisartan 20mg+amlodipine 2.5mg+indapamide 1.25mg, for 2ry prevention after ICH 1670pts, ~58y, 33%female 1ry outcome, recurrent stroke: HR 0.61 p=0.017 NNT 27 👏👏 The George Institute for Global Health
#WSC2025 #Oceanic_Stroke Dr Sharma presenting data on #asundexian 50mg vs placebo for non cardiembolic stroke NIHSS<15, high-risk TIA (ABCD2 6 or 7) < 72 hours of onset, with at least 1 atherosclerosis marker Trial completion is anticipated in October 2025. Ashkan Shoamanesh
Iniciando Global Stroke Alliance #GSA2025 Congreso SIECV-IASO desde Panamá 🇵🇦 Dr. Pablo Lavados presidente SIECV en sesión inicial
We are absolutely thrilled to share that the OCEANIC-STROKE trial has successfully met its primary efficacy & safety endpoints. These landmark findings have the potential to prevent >1M strokes annually worldwide... bayer.com/media/en-us/ba… Mike Sharma PHRI.ca Population Health Research Institute 🇨🇦